← Browse by Condition
Medical Condition
schizoaffective disorder
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 4, Phase 3
ClinicalMetric tracks all active clinical trials for schizoaffective disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — schizoaffective disorder Clinical Trials
How many clinical trials are currently recruiting for schizoaffective disorder?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for schizoaffective disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for schizoaffective disorder?
schizoaffective disorder research spans Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a schizoaffective disorder clinical trial?
Eligibility criteria for schizoaffective disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Phase 4 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07105111 Phase 4
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT07098169
Recruiting
Enrollment
201 pts
Location
United States
Sponsor
University of California, San ...
NCT06898879
Recruiting
Enrollment
119 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT07263022 Phase 3
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
University of Minnesota
NCT06221852
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Mclean Hospital
NCT07703670
Recruiting
Enrollment
160 pts
Location
United States
Sponsor
Northwell Health
NCT06672588
Recruiting
Enrollment
80 pts
Location
Canada
Sponsor
Centre for Addiction and Menta...
NCT02639702 Phase 4
Recruiting
Enrollment
30 pts
Location
Canada
Sponsor
Centre for Addiction and Menta...
Related Conditions
schizophrenia (4) bipolar disorder (2) major depressive disorder (2) psychotic disorder (2) psychosis (2) schizophrenia disorder (2) schizophreniform disorder (2) tardive dyskinesia (1) schizophrenia disorders (1) delusional disorder (1) major depressive disorder with psychotic features (1) bipolar disorder with psychotic features (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology